Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
<h4>Background</h4>The coronavirus disease 2019 (COVID-19) pandemic rapidly increases the use of mechanical ventilation (MV). Such cases further require extracorporeal membrane oxygenation (ECMO) and have a high mortality.<h4>Objective</h4>We aimed to identify prognostic biom...
Main Authors: | Ryo Saji, Mototsugu Nishii, Kazuya Sakai, Kei Miyakawa, Yutaro Yamaoka, Tatsuma Ban, Takeru Abe, Yutaro Ohyama, Kento Nakajima, Taro Hiromi, Reo Matsumura, Naoya Suzuki, Hayato Taniguchi, Tsuyoshi Otsuka, Yasufumi Oi, Fumihiro Ogawa, Munehito Uchiyama, Kohei Takahashi, Masayuki Iwashita, Yayoi Kimura, Satoshi Fujii, Ryosuke Furuya, Tomohiko Tamura, Akihide Ryo, Ichiro Takeuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0256022 |
Similar Items
-
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19
by: Ryo Saji, et al.
Published: (2021-01-01) -
Therapeutic strategy for severe COVID-19 pneumonia from clinical experience
by: Fumihiro Ogawa, et al.
Published: (2020-09-01) -
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19
by: Fumihiro Ogawa, et al.
Published: (2021-08-01) -
Combining blood glucose and SpO2/FiO2 ratio facilitates prediction of imminent ventilatory needs in emergency room COVID-19 patients
by: Kazuya Sakai, et al.
Published: (2023-12-01) -
Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
by: Yusuke Nakai, et al.
Published: (2022-11-01)